Subclinical atherosclerosis in patients with rheumatoid arthritis

P Ambrosino, R Lupoli, A Di Minno… - Thrombosis and …, 2015 - thieme-connect.com
We performed a systematic review with meta-analysis and meta-regression of literature
studies evaluating the impact of rheumatoid arthritis (RA) on common carotid artery intima …

Subclinical atherosclerosis in systemic lupus erythematosus: comparable risk with diabetes mellitus and rheumatoid arthritis

MG Tektonidou, E Kravvariti, G Konstantonis… - Autoimmunity …, 2017 - Elsevier
Objective Although a high risk of subclinical atherosclerosis has been reported in Systemic
Lupus Erythematosus (SLE), it is not adequately compared with that observed in other …

The lipid paradox in rheumatoid arthritis: the dark horse of the augmented cardiovascular risk

AI Venetsanopoulou, E Pelechas, PV Voulgari… - Rheumatology …, 2020 - Springer
Rheumatoid arthritis (RA) is an autoimmune disease characterized by chronic inflammation
that, if left untreated, can cause joint destruction and physical impairments. The inflammatory …

The lipid paradox as a metabolic checkpoint and its therapeutic significance in ameliorating the associated cardiovascular risks in rheumatoid arthritis patients

T Behl, I Kaur, A Sehgal, G Zengin, C Brisc… - International journal of …, 2020 - mdpi.com
While the most common manifestations associated with rheumatoid arthritis (RA) are
synovial damage and inflammation, the systemic effects of this autoimmune disorder are life …

Effect of leptin on chronic inflammatory disorders: insights to therapeutic target to prevent further cardiovascular complication

G Dessie, B Ayelign, Y Akalu, T Shibabaw… - … Syndrome and Obesity, 2021 - Taylor & Francis
In response to obesity-associated chronic inflammatory disorders, adipose tissue releases a
biologically active peptide known as leptin. Leptin activates the secretion of chemical …

Lipid and metabolic changes in rheumatoid arthritis

CM McGrath, SP Young - Current rheumatology reports, 2015 - Springer
While the most obvious manifestations of rheumatoid arthritis (RA) involve inflammation and
damage in the synovial joints, the systemic effects of the condition are widespread and life …

Atherosclerosis is not accelerated in rheumatoid arthritis of low activity or remission, regardless of antirheumatic treatment modalities

A Arida, AD Protogerou, G Konstantonis… - …, 2017 - academic.oup.com
Objectives. RA associates with increased cardiovascular disease (CVD) morbidity and
mortality due to accelerated atherosclerosis, attributed to both classical risk factors and …

Glucocorticoids in rheumatoid arthritis: the silent companion in the therapeutic strategy

O Berardicurti, P Ruscitti, V Pavlych… - Expert Review of …, 2020 - Taylor & Francis
ABSTRACT Introduction Glucocorticoids (GCs) are key actors in RA management, despite
the increasing number of available drugs. In fact, due to their efficacy and safety, the …

Local cryotherapy improves adjuvant-induced arthritis through down-regulation of IL-6/IL-17 pathway but independently of TNFα

X Guillot, H Martin, S Seguin-Py, K Maguin-Gaté… - PLoS …, 2017 - journals.plos.org
Objectives Local cryotherapy is widely and empirically used in the adjuvant setting in
rheumatoid arthritis treatment, however its own therapeutic and anti-inflammatory effects are …

Interrelated reduction of chemerin and plasminogen activator inhibitor-1 serum levels in rheumatoid arthritis after interleukin-6 receptor blockade

K Makrilakis, K Fragiadaki, J Smith, PP Sfikakis… - Clinical …, 2015 - Springer
Inflammatory/metabolic factors and imbalance of haemostasis contribute to cardiovascular
disease risk in rheumatoid arthritis (RA). Interleukin-6 (IL-6), a cytokine that plays an …